AU2002337196A1 - Use of cardiotrophin in hepatic diseases - Google Patents

Use of cardiotrophin in hepatic diseases

Info

Publication number
AU2002337196A1
AU2002337196A1 AU2002337196A AU2002337196A AU2002337196A1 AU 2002337196 A1 AU2002337196 A1 AU 2002337196A1 AU 2002337196 A AU2002337196 A AU 2002337196A AU 2002337196 A AU2002337196 A AU 2002337196A AU 2002337196 A1 AU2002337196 A1 AU 2002337196A1
Authority
AU
Australia
Prior art keywords
cardiotrophin
hepatic diseases
hepatic
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002337196A
Other versions
AU2002337196B2 (en
Inventor
Elena Baixeras Llano
Matilde Bustos De Abajo
Juan Jose Lasarte Sagastibelza
Jesus Prieto Valtuena
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proyecto de Biomedicina CIMA SL
Original Assignee
Proyecto de Biomedicina CIMA SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200102120A external-priority patent/ES2200646B1/en
Application filed by Proyecto de Biomedicina CIMA SL filed Critical Proyecto de Biomedicina CIMA SL
Publication of AU2002337196A1 publication Critical patent/AU2002337196A1/en
Assigned to PROYECTO DE BIOMEDICINA CIMA, S.L. reassignment PROYECTO DE BIOMEDICINA CIMA, S.L. Request for Assignment Assignors: FUNDACION PARA LA INVESTIGACION MEDICA APLICADA
Application granted granted Critical
Publication of AU2002337196B2 publication Critical patent/AU2002337196B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002337196A 2001-09-21 2002-09-20 Use of cardiotrophin in hepatic diseases Ceased AU2002337196B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200102120 2001-09-21
ES200102120A ES2200646B1 (en) 2001-09-21 2001-09-21 USE OF CARDIOTROPHIN IN HEPATIC DISEASES.
PCT/ES2002/000445 WO2003027146A1 (en) 2001-09-21 2002-09-20 Use of cardiotrophin in hepatic diseases

Publications (2)

Publication Number Publication Date
AU2002337196A1 true AU2002337196A1 (en) 2003-06-26
AU2002337196B2 AU2002337196B2 (en) 2008-03-13

Family

ID=8498979

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002337196A Ceased AU2002337196B2 (en) 2001-09-21 2002-09-20 Use of cardiotrophin in hepatic diseases

Country Status (17)

Country Link
US (1) US7732397B2 (en)
EP (1) EP1437365B1 (en)
JP (1) JP4290004B2 (en)
CN (1) CN1243020C (en)
AT (1) ATE416194T1 (en)
AU (1) AU2002337196B2 (en)
BR (1) BR0212903A (en)
CA (1) CA2461007C (en)
CY (1) CY1109800T1 (en)
DE (1) DE60230172D1 (en)
DK (1) DK1437365T3 (en)
ES (2) ES2200646B1 (en)
MX (1) MXPA04002672A (en)
PT (1) PT1437365E (en)
RU (1) RU2279289C2 (en)
SI (1) SI1437365T1 (en)
WO (1) WO2003027146A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2344204T3 (en) * 2003-06-25 2010-08-20 Ottawa Hospital Research Institute USE OF CARDIOTROPHIN TO MODULATE THE PROLIFERATION OF MOTHER CELLS.
ES2302402B1 (en) * 2005-06-16 2009-05-08 Proyecto De Biomedicina Cima, S.L. USE OF A CYTOQUINE OF THE INTERLEUQUINA-6 FAMILY IN THE PREPARATION OF A COMPOSITION FOR ADMINISTRATION COMBINED WITH INTERFERON-ALFA.
JP2013526600A (en) * 2010-05-24 2013-06-24 ディグナ ビオテク、エセ エレ Cold organ preservation composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE339503T1 (en) 1994-04-25 2006-10-15 Genentech Inc CARDIOTROPHIN AND USE THEREOF
JP2002534987A (en) * 1999-01-21 2002-10-22 ジェネンテック・インコーポレーテッド Compositions and methods for treating tumors
US6719969B1 (en) * 1999-08-09 2004-04-13 The Regents Of The University Of Michigan Treatment of liver disease and injury with CXC chemokines
JP2005504010A (en) * 2001-05-17 2005-02-10 ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ Method for treating liver disease and liver injury using growth hormone and FOXM1B

Similar Documents

Publication Publication Date Title
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2002359163A1 (en) New use
AU2003227189A1 (en) Cleansing preparation
IL164463A (en) Use of osteoprotegerin in the preparation of medicaments
AU2003293644A1 (en) Moldings and preparation and uses thereof
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003258937A1 (en) Naphthyl ether compounds and their use
AU2002227925A1 (en) Human beta-defensin-3
AU2001241162A1 (en) Remedies for allergic diseases
AU2002337196A1 (en) Use of cardiotrophin in hepatic diseases
AU4432001A (en) Trityl-type compounds and their use
AU2002338509B2 (en) Improvements in and relating to the administration of copper to an animal
AU2003263895A1 (en) Contraceptive methods and formulations
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU8770201A (en) Intermediates for use in the preparation of vitamin e
WO2005042707A9 (en) Taspasel 1 and methods of use
AU2003235326A1 (en) External preparation for allergic diseases
AU2002356679A1 (en) Clusianon isomers and use thereof
AU2002215923A1 (en) Use of medicaments
AU2001287897A1 (en) Manipulation of spermatozoa
AU2003276500A1 (en) Omega-substituted-naphthyloxyalklamino derivatives as antihyperglycemic agents and preparation
AU2002256665A1 (en) 1-Butyric acid derivatives and their use
AU2002351972A1 (en) Sulphatases and use thereof
AU2002305940A1 (en) Neuroprotectants formulations and methods